Metabolic imaging with deuterium labeled substrates.

Deuterium metabolic imaging (DMI) is an emerging clinically-applicable technique for the non-invasive investigation of tissue metabolism. The generally short T ₁ values of ² H-labeled metabolites in vivo can compensate for the relatively low sensitivity of detection by allowing rapid signal acquisition in the absence of significant signal saturation. Studies with deuterated substrates, including [6,6'- ² H ₂ ]glucose, [ ² H ₃ ]acetate, [ ² H ₉ ]choline and [2,3- ² H ₂ ]fumarate have demonstrated the considerable potential of DMI for imaging tissue metabolism and cell death in vivo. The technique is evaluated here in comparison with established metabolic imaging techniques, including PET measurements of 2-deoxy-2-[ ¹⁸ F]fluoro-d-glucose (FDG) uptake and ¹³ C MR imaging of the metabolism of hyperpolarized ¹³ C-labeled substrates.
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.)